Table of Contents
A collaboration between the University of Miami Miller School of Medicine and health technology company Amalgam Rx is helping shape the next generation of artificial intelligence for health care. The partnership recently earned national recognition when the Chiron healthcare AI model was named “Overall Large Language Model of the Year” by the 2026 AI Breakthrough Awards, a global competition that drew more than 5,000 nominations from more than 20 countries.
A Notable Recognition for the Chiron Healthcare AI Model
The honor places Chiron among technology innovations recognized alongside previous award winners such as NVIDIA, Qualcomm and Snowflake. While Amalgam developed the underlying AI platform, Azizi Seixas, PhD, professor of psychiatry and behavioral sciences, director of the Media and Innovation Lab, co-director of the Center for Translational Sleep and Circadian Sciences, and interim chair of the Department of Informatics and Health Data Science at the Miller School, has played a leading role in identifying how the technology can be applied in real-world health care settings.
A Shared Vision for Medical-Grade AI
“The partnership between Amalgam and the Media and Innovation Lab represents a shared vision to shape the future of medical-grade artificial intelligence and learning health systems,” said Seixas. “Together, we are working to ensure that next-generation AI moves beyond technological innovation to become safely integrated into routine clinical care, where it can improve decision-making, personalize treatment and enhance patient outcomes.”
Academic Medicine’s Growing Role in the Chiron Healthcare AI Model
The collaboration reflects a growing role for academic medical centers in shaping health care AI, ensuring that new technologies are not only technically sophisticated but also scientifically validated, clinically useful and responsibly deployed. At the Miller School, researchers are helping establish the framework needed to evaluate, implement and continuously improve AI-powered tools within health care systems.
Understanding the Entire Patient Journey
At the center of the recognition is Chiron, a health care-specific large language model designed to analyze a patient’s complete medical history rather than isolated clinical encounters. Unlike general-purpose AI systems, the Chiron healthcare AI model is trained to interpret diagnoses, medications, laboratory results, referrals, comorbidities and other longitudinal health care data simultaneously.
How the Chiron Healthcare AI Model Identifies Patient Risk
By analyzing how those events unfold over time, the model can identify patterns that may signal emerging health risks or opportunities for earlier intervention. “Chiron is designed to understand the complete clinical journey of a patient rather than isolated health care encounters,” Seixas said. “What makes Chiron unique is its ability to synthesize complex health care data into meaningful clinical reasoning while operating within the realities of health care delivery.”
Why Longitudinal Data Matters
The model’s design reflects a fundamental reality of medicine: health care decisions are rarely based on a single encounter. “Health care is inherently longitudinal,” Seixas said. “Every diagnosis, medication change, referral, hospitalization and clinical encounter represents part of a patient’s health story rather than an isolated event.” By understanding those events as connected parts of a larger narrative, the Chiron healthcare AI model may help clinicians detect disease earlier, identify high-risk patients, and personalize treatment decisions.
Bridging Innovation and Implementation for the Chiron Healthcare AI Model
A key aspect of Seixas’s involvement has been ensuring that the technology can be integrated into health care environments in ways that support clinicians and patients. “My role has centered on identifying clinically meaningful applications for this technology and developing strategies to integrate it into health care delivery,” he said. “As an implementation scientist, informatician and digital health researcher, my focus is understanding how AI can be translated from promising technology into sustainable clinical practice.”
An Initial Focus on Sleep Apnea
The partnership’s initial use case focused on sleep apnea. “This approach can help examine a very common but often overlooked disorder that affects brain, cardiovascular and metabolic health over time,” said Alberto Ramos, MD, a professor of neurology and research director of the sleep program at the Miller School, who contributed to the project. “AI that can recognize these longitudinal patterns has the potential to help clinicians identify high-risk patients earlier and deliver more personalized care.”
What This Recognition Means for the Future of Clinical AI
With the Chiron healthcare AI model now recognized as a leading large language model in the industry, its emphasis on longitudinal patient data analysis and proactive care may offer a template for how academic-industry partnerships can move healthcare AI beyond episodic, reactive applications. As Chiron’s initial use case in sleep apnea detection matures, its underlying approach to synthesizing complex, time-spanning patient data could inform how similar models are developed and validated across other chronic and often-overlooked health conditions in the years ahead.
For more healthcare industry updates, insights and news, visit DistilINFO. Click here to subscribe to stay informed.
